US Stock MarketDetailed Quotes

UTMD Utah Medical Products

Watchlist

61.918
+0.488+0.79%

Trading Dec 26 14:50 ET

210.00MMarket Cap14.47P/E (TTM)

Utah Medical Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-19.99%10.01M

-19.17%10.4M

-9.42%11.34M

-3.93%50.22M

-9.14%12.33M

-3.47%12.51M

-4.19%12.87M

1.60%12.52M

6.58%52.28M

5.11%13.57M

Operating revenue

-19.99%10.01M

-19.17%10.4M

-9.42%11.34M

-3.93%50.22M

-9.14%12.33M

-3.47%12.51M

-4.19%12.87M

1.60%12.52M

6.58%52.28M

5.11%13.57M

Cost of revenue

-18.32%4.2M

-19.11%4.15M

-2.20%4.57M

0.50%20.19M

-0.23%5.24M

7.91%5.15M

-2.84%5.13M

-2.36%4.68M

10.74%20.09M

9.29%5.25M

Gross profit

-21.16%5.8M

-19.20%6.25M

-13.73%6.77M

-6.70%30.04M

-14.76%7.1M

-10.10%7.36M

-5.05%7.74M

4.12%7.84M

4.14%32.2M

2.64%8.33M

Operating expense

-27.46%2.46M

-15.06%2.82M

-28.58%2.14M

6.89%13.26M

-3.16%3.15M

11.33%3.39M

7.11%3.31M

-0.53%3M

3.07%12.41M

9.19%3.26M

Selling and administrative expenses

-29.67%2.29M

-19.52%2.56M

8.39%1.37M

6.61%12.7M

-4.02%3.01M

10.88%3.25M

7.50%3.18M

-56.27%1.26M

3.49%11.91M

10.27%3.13M

-Selling and marketing expense

----

6.46%412K

11.81%1.69M

----

--387K

6.58%1.51M

----

-General and administrative expense

----

9.25%957K

5.86%11.02M

----

--876K

3.06%10.41M

----

Research and development costs

24.64%172K

91.73%255K

84.72%266K

13.59%560K

18.70%146K

23.21%138K

-1.48%133K

17.07%144K

-6.27%493K

-12.77%123K

Depreciation amortization depletion

----

-68.26%504K

----

--1.59M

----

-Depreciation and amortization

----

-68.26%504K

----

--1.59M

----

Operating profit

-15.77%3.34M

-22.31%3.44M

-4.56%4.63M

-15.22%16.78M

-22.21%3.94M

-22.80%3.97M

-12.50%4.43M

7.21%4.85M

4.82%19.79M

-1.17%5.07M

Net non-operating interest income expense

Other net income (expense)

2.96%836K

3.48%773K

-36.53%172K

281.13%3.31M

105.95%1.07M

310.10%812K

426.06%747K

3,287.50%271K

380.11%869K

921.57%521K

Gain on sale of security

----

359.30%3.04M

----

298.19%661K

----

Special income (charges)

----

-81.66%-743K

----

---409K

----

-Less:Other special charges

----

81.66%743K

----

--409K

----

Other non- operating income (expenses)

2.96%836K

3.48%773K

34.56%915K

32.69%276K

-1,302.14%-1.96M

310.10%812K

426.06%747K

8,400.00%680K

1,286.67%208K

-21.74%-140K

Income before tax

-12.59%4.18M

-18.58%4.21M

-6.27%4.8M

-2.76%20.09M

-10.27%5.02M

-10.45%4.78M

-0.52%5.17M

13.00%5.12M

8.38%20.66M

7.91%5.59M

Income tax

-27.19%616K

-22.02%758K

-6.96%842K

-17.49%3.45M

-29.44%731K

-20.11%846K

-11.31%972K

-9.14%905K

-2.04%4.19M

-1.24%1.04M

Net income

-9.45%3.56M

-17.79%3.45M

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

Net income continuous Operations

-9.45%3.56M

-17.79%3.45M

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

Minority interest income

Net income attributable to the parent company

-9.45%3.56M

-17.79%3.45M

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-9.45%3.56M

-17.79%3.45M

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.36%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

Basic earnings per share

-5.56%1.02

-15.52%0.98

-6.03%1.09

1.10%4.58

-5.94%1.181

-8.47%1.08

2.65%1.16

19.59%1.16

11.85%4.53

11.08%1.2555

Diluted earnings per share

-5.56%1.02

-14.78%0.98

-6.03%1.09

1.11%4.57

-5.83%1.18

-8.47%1.08

2.68%1.15

20.83%1.16

11.88%4.52

11.18%1.253

Dividend per share

1.69%0.3

1.72%1.185

1.69%0.3

1.72%0.295

36.26%1.165

0.295

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	-19.99%10.01M	-19.17%10.4M	-9.42%11.34M	-3.93%50.22M	-9.14%12.33M	-3.47%12.51M	-4.19%12.87M	1.60%12.52M	6.58%52.28M	5.11%13.57M
Operating revenue	-19.99%10.01M	-19.17%10.4M	-9.42%11.34M	-3.93%50.22M	-9.14%12.33M	-3.47%12.51M	-4.19%12.87M	1.60%12.52M	6.58%52.28M	5.11%13.57M
Cost of revenue	-18.32%4.2M	-19.11%4.15M	-2.20%4.57M	0.50%20.19M	-0.23%5.24M	7.91%5.15M	-2.84%5.13M	-2.36%4.68M	10.74%20.09M	9.29%5.25M
Gross profit	-21.16%5.8M	-19.20%6.25M	-13.73%6.77M	-6.70%30.04M	-14.76%7.1M	-10.10%7.36M	-5.05%7.74M	4.12%7.84M	4.14%32.2M	2.64%8.33M
Operating expense	-27.46%2.46M	-15.06%2.82M	-28.58%2.14M	6.89%13.26M	-3.16%3.15M	11.33%3.39M	7.11%3.31M	-0.53%3M	3.07%12.41M	9.19%3.26M
Selling and administrative expenses	-29.67%2.29M	-19.52%2.56M	8.39%1.37M	6.61%12.7M	-4.02%3.01M	10.88%3.25M	7.50%3.18M	-56.27%1.26M	3.49%11.91M	10.27%3.13M
-Selling and marketing expense	----	----	6.46%412K	11.81%1.69M	----	----	----	--387K	6.58%1.51M	----
-General and administrative expense	----	----	9.25%957K	5.86%11.02M	----	----	----	--876K	3.06%10.41M	----
Research and development costs	24.64%172K	91.73%255K	84.72%266K	13.59%560K	18.70%146K	23.21%138K	-1.48%133K	17.07%144K	-6.27%493K	-12.77%123K
Depreciation amortization depletion	----	----	-68.26%504K	----	----	----	----	--1.59M	----	----
-Depreciation and amortization	----	----	-68.26%504K	----	----	----	----	--1.59M	----	----
Operating profit	-15.77%3.34M	-22.31%3.44M	-4.56%4.63M	-15.22%16.78M	-22.21%3.94M	-22.80%3.97M	-12.50%4.43M	7.21%4.85M	4.82%19.79M	-1.17%5.07M
Net non-operating interest income expense
Other net income (expense)	2.96%836K	3.48%773K	-36.53%172K	281.13%3.31M	105.95%1.07M	310.10%812K	426.06%747K	3,287.50%271K	380.11%869K	921.57%521K
Gain on sale of security	----	----	----	359.30%3.04M	----	----	----	----	298.19%661K	----
Special income (charges)	----	----	-81.66%-743K	----	----	----	----	---409K	----	----
-Less:Other special charges	----	----	81.66%743K	----	----	----	----	--409K	----	----
Other non- operating income (expenses)	2.96%836K	3.48%773K	34.56%915K	32.69%276K	-1,302.14%-1.96M	310.10%812K	426.06%747K	8,400.00%680K	1,286.67%208K	-21.74%-140K
Income before tax	-12.59%4.18M	-18.58%4.21M	-6.27%4.8M	-2.76%20.09M	-10.27%5.02M	-10.45%4.78M	-0.52%5.17M	13.00%5.12M	8.38%20.66M	7.91%5.59M
Income tax	-27.19%616K	-22.02%758K	-6.96%842K	-17.49%3.45M	-29.44%731K	-20.11%846K	-11.31%972K	-9.14%905K	-2.04%4.19M	-1.24%1.04M
Net income	-9.45%3.56M	-17.79%3.45M	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M
Net income continuous Operations	-9.45%3.56M	-17.79%3.45M	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M
Minority interest income
Net income attributable to the parent company	-9.45%3.56M	-17.79%3.45M	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-9.45%3.56M	-17.79%3.45M	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.36%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M
Basic earnings per share	-5.56%1.02	-15.52%0.98	-6.03%1.09	1.10%4.58	-5.94%1.181	-8.47%1.08	2.65%1.16	19.59%1.16	11.85%4.53	11.08%1.2555
Diluted earnings per share	-5.56%1.02	-14.78%0.98	-6.03%1.09	1.11%4.57	-5.83%1.18	-8.47%1.08	2.68%1.15	20.83%1.16	11.88%4.52	11.18%1.253
Dividend per share	1.69%0.3	1.69%0.3	1.69%0.3	1.72%1.185	1.69%0.3	1.72%0.295	1.72%0.295	1.72%0.295	36.26%1.165	0.295
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data